New eye lens could let you focus without glasses after cataract surgery

NCT ID NCT07147192

Recruiting now Disease control Sponsor: Alcon Research Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new type of intraocular lens (IOL) that can be adjusted after cataract surgery using laser energy, potentially allowing the eye to focus at different distances. Researchers will enroll 85 adults with cataracts in both eyes to check safety and how well the lens works. The goal is to see if this lens can improve vision and reduce dependence on glasses.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: intraocular lens (IOL) implant
What this could lead to: If successful, this lens could help people see clearly at multiple distances after cataract surgery, reducing the need for glasses.
What could go wrong: This is an early feasibility study with only 85 people, so results may not apply to everyone. There are risks of side effects like inflammation or need for additional surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APHAKIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aphakia cataract congenital primary aphakia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

APHAKIA

Contacts and locations

Locations

Centro Panamericano de Ojos / Clinica Lopez Beltran
NOT_YET_RECRUITING

San Salvador, El Salvador
Clinica 20/20
RECRUITING

San José, Costa Rica
Instituto Espaillat Cabral
NOT_YET_RECRUITING

Santo Domingo, Dominican Republic
Panama Eye Center
RECRUITING

Panama City, Panama

More trials for these conditions

Other studies related to the condition(s) this trial covers.